Utama › Kekurangan Alpha-1 Antitripsin › Ohio
Kajian klinikal Kekurangan Alpha-1 Antitripsin di Ohio
3 kajian untuk Kekurangan Alpha-1 Antitripsin sedang mencari peserta di lokasi di Ohio.
Bandar di Ohio
Teks kajian rasmi (Bahasa Inggeris)
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 104, Cleveland
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT07555483Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- University Hospitals Cleveland Medical Center, Cleveland
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 13 Mei 2026 · NCT05677971Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- University Hospitals Cleveland Medical Center, Cleveland
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 5 Mac 2026 · NCT06165341Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.